Based on the GRI Bio Inc. stock forecast from 0 analysts, the average analyst target price for GRI Bio Inc. is not available over the next 12 months. GRI Bio Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of GRI Bio Inc. is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, GRI Bio Inc.’s stock price was USD 0.67. GRI Bio Inc.’s stock price has changed by -8.38% over the past week, -9.19% over the past month and -97.33% over the last year.
No recent analyst target price found for GRI Bio Inc.
No recent average analyst rating found for GRI Bio Inc.
Company Overview GRI Bio Inc.
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for GRI Bio Inc. (GRI)
Loading...
Unadjusted Closing Price for GRI Bio Inc. (GRI)
Loading...
Share Trading Volume for GRI Bio Inc. Shares
Loading...
Compare Performance of GRI Bio Inc. Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for GRI
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To GRI Bio Inc. (Sector: Biotechnology )
Frequently Asked Questions About GRI Bio Inc. (GRI) Stock
Stock Target Advisor's fundamental analysis for GRI Bio Inc.'s stock is Very Bearish.
Unfortunately we do not have enough data on GRI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on GRI's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on GRI's stock to indicate if its overvalued.
The last closing price of GRI's stock was USD 0.67.
Unfortunately we do not currently have any market capitalization data for GRI's stock.
Unfortunately we do not have enough analyst data on GRI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains GRI Bio Inc.'s stock.
Sorry, we do not have any data on the number of employees for GRI Bio Inc..
Sorry we do not have any infomation available on GRI Bio Inc.'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About GRI Bio Inc. (GRI) Stock
Stock Target Advisor's fundamental analysis for GRI Bio Inc.'s stock is Very Bearish.
Unfortunately we do not have enough data on GRI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on GRI's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on GRI's stock to indicate if its overvalued.
The last closing price of GRI's stock was USD 0.67.
Unfortunately we do not currently have any market capitalization data for GRI's stock.
Unfortunately we do not have enough analyst data on GRI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains GRI Bio Inc.'s stock.
Sorry, we do not have any data on the number of employees for GRI Bio Inc..
Sorry we do not have any infomation available on GRI Bio Inc.'s address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GRI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
